News

16th World Congress on Targeting Mitochondria | 2025

Joomla! provides plenty of flexibility when displaying your Web content. Whether you are using Joomla! for a blog site, news or a Web site for a company, you'll find one or more content styles to showcase your information. You can also change the style of content dynamically depending on your preferences. Joomla! calls how a page is laid out a layout. Use the guide below to understand which layouts are available and how you might use them.

MitoSense is Supporting Targeting Mitochondria 2024

MitoSense

MitoSense will be sponsoring the 15th WMS Annual Meeting, Targeting Mitochondria 2024, on October 29-31 at DoubleTree by Hilton Berlin Ku'damm, Berlin, Germany.

About MitoSense

MitoSense, Inc. is a research and development company in the field of securing development of treatments for neurodegenerative diseases. With exclusively licensed technology to replenish the mitochondria in humans using Mitochondria Organelle Transplantation (MOT™️), the company, through its U.S. based research partner is initially focusing its efforts on treating ALS. MOT™️ may impact research for patients with Alzheimer’s, Parkinson’s, Huntington’s and other neurodegenerative diseases, none of which have a cure.

What do they do?

MitoSense uses a proprietary (patent pending) technique to replenish mitochondria to treat ALS. The technique has the potential to treat a wide range of indications including Alzheimer’s, Parkinson’s, Huntington’s, Multiple Sclerosis and other neurodegenerative diseases. With experienced leadership in business, government, research, and medical, we have brought together a multidisciplinary team to help in the fight.

Talk at Targeting Mitochondria 2024:

Dr. Mark Kindy, U.S. Department of Veterans Affairs James A. Haley VA Hospital and University of South Florida will be presenting a major talk during the meeting in Berlin: "Mitochondrial Transplantation Mediates Improved Cellular Energy Metabolism, Restoration of Mitochondrial Function and Prevention of Cell Death". His team at the VA is collaborating with MitoSense.

In his talk Dr. Kindy will cover:

Isolation and characterization of mitochondria
Application of mitochondrial transplantation
Reversal of cellular dysfunction
Restoration of energy metabolism

MitoSense Website:

https://www.mitosenseinc.com/

MitoSense is collaborating with Dr. Kindy.

Speakers 2024

Keynote Speech - Day 1
Mitochondria in Alzheimer disease: it's not what you think
Eric Schon, Columbia University, USA

Keynote Speech - Day 2
Mitochondria: More Heat than Light?
Howy Jacobs, Tampere University, Finland

The Role of Mitochondria in Zika Virus Propagation: Mechanisms of Immune Evasion and Inter-Cellular Transmission
Indira Mysorekar, Baylor College of Medicine, USA

Mitochondrial Extracellular Vesicles: Orchestrating Brain Plasticity and Recovery
Stefano Pluchino, University of Cambridge, United Kingdom

Mitochondria Function Evaluation: Workshop Highlights, Methods, Discrepancies, and Recommendations
Naig Gueguen, CHU Angers, France

Mitochondria and Photomedicine: Advances in Infrared Light Treatment
Maik Hüttemann, Wayne State University, USA

Cellular Dynamics: The Synergistic Interplay of Iron, Mitochondria, and Ferroptosis in Health and Disease
Carsten Culmsee, University of Marburg, Germany

Mitochondria Iron Metabolism: Its Role in Pathogenesis of Diseases
Sonia Levi, Vita-Salute San Raffaele University, Italy

Stem Cell Educator Therapy: A New Era in Mitochondrial Transfer and Regeneration
Yong Zhao, Throne Biotechnologies, USA

Evaluation and Quality Control of Mitochondrial Function: Where we are Now & What's Next?
Egbert Mik, Erasmus MC, The Netherlands

Mitochondria Delivery via Extracellular Vesicles to the Blood-Brain Barrier
Devika S Manickam, Duquesne University, USA

Mitochondrial Transplantation Mediates Improved Cellular Energy Metabolism, Restoration of Mitochondrial Function and Prevention of Cell Death
Mark Kindy, U.S. Department of Veterans Affairs James A. Haley VA Hospital and University of South Florida

Investigating Mitochondria as Age-Old Drivers of Inflammation
Stephen Tait, University of Glasgow, United Kingdom

The Intersection of Mitochondrial Function and Psychiatric Disorders: Biomarkers, Gene Variants, and Patient Stratification
Ana Andreazza, University of Toronto, Canada

The Power and Potential of Mitochondria Transfer
Jonathan R. Brestoff, Washington University in St. Louis School of Medicine, USA

Mitochondrial Dynamics: Updates and Perspectives
Ježek Petr, Institute of Physiology of the Czech Academy of Sciences, Czech Republic

Cracking the Code of Aging: Exploring Mitochondrial Dynamics and Organelle Connections
Antentor Hinton, Vanderbilt University, USA

State of the Science Mitochondria-specific Targets, Therapeutics and Biomarkers Investigation following Traumatic Brain Injury in the US Military
Jignesh D. Pandya, Walter Reed Army Institute of Research, USA

Blood-Based Marker: Mitochondrial DNA Damage in Parkinson’s Disease
Laurie Sanders, Duke University School of Medicine, USA

New Biosensing Solutions and Optimized Pharmacological Inhibitors to Counteract Mitophagy in Cancer Cells
Giulia Bertolin, CNRS, Université de Rennes, France

Dynamics of Mitochondria: Regulation of Nucleoid Morphology to Protect Mitochondrial Function
Naotada Ishihara, Osaka University, Japan

Role of Light in Regulating Blood Glucose via Mitochondrial Stimulation
Michael B. Powner, City University of London, United Kingdom

Targeting Giant Mitochondria (Megamitochondria) in Human Liver Disease: Potential Diagnostic and Therapeutic Interventions
Elena Palma, King's College London, United Kingdom

Targeting Mitochondria 2023 Replay & Abstracts Book are Available

Targeting Mitochondria 2023 Abstracts Book Targeting Mitochondria 2023 abstract book is now available. It compiles all 82+ communications along with speaker details and emails for direct connections. Order Abstracts Book.

On-demand content make it easier for you to access the presentations at your convenience. Targeting Mitochondria 2023 replay will be available after the conference. Order 3-weeks Replay Access.